全球基因组编辑市场 – 行业趋势及 2030 年预测

基因组编辑市场分析和规模

基因组编辑是一种相对较新的改变特定 DNA 序列的技术。在基础生物医学研究中，利用细菌免疫系统（一种强大的基因组编辑工具）修改基因组来检查基因功能已成为一种常见做法。该技术越来越多地用于研究和治疗人类疾病，通过改变注入体内的人类血细胞来治疗各种疾病，如囊性纤维化、癌症和艾滋病。                

Data Bridge Market Research 分析，全球基因组编辑市场规模在 2022 年为 55.1213 亿美元，预计到 2030 年将达到 184.0023 亿美元，预计在 2023 年至 2030 年的预测期内复合年增长率为 17.2%。由于对基因组编辑的需求不断增长，“CRISPR”在全球基因组编辑市场的技术领域占据主导地位。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

基因组编辑市场范围和细分

市场定义

基因组编辑是一种精确改变生物体或细胞 DNA 的技术。它可用于改变任何生物体的基因组。它使用一种称为“工程核酸酶”的特殊酶，对基因组进行精确切割。DNA 的特定区域被切割，细胞会自动修复损伤。它可用于农业、生物技术、医药和突变等各个领域。慢性病和传染病的患病率可能会增加，从而扩大基因组编辑的应用范围。

全球基因组编辑市场动态

驱动程序

• 基因组编辑的发展

该领域的最新进展显著提高了基因组编辑能力，使得人们能够改变多种细胞类型和模型物种中感兴趣的基因序列。基因组工程已发展成为一种可能改变肿瘤学研究游戏规则的诊断工具。政府和学术研究机构等大型研究组织都使用了基因组工程。基因编辑技术的快速发展是这种从学术界向临床和诊断实验室彻底转变的主要推动力。

• 基因组学的应用领域不断扩大

Application areas for genomics include drug research, agribusiness, veterinary sciences, forensics, and the identification of human genetic abnormalities. The use of genomics in forensic studies has dramatically risen, largely to products provided by Illumina (U.S.), which were created especially for the field. Earlier, DNA analysis was utilized for fingerprint profiling. NGS aids in crime scene analysis and makes it possible to recover more information from a trace or damaged DNA sample, which is expected to drive market growth.

• Advancements in CRISPR-Cas9 Technology

The rapid evolution of the CRISPR-Cas9 genome editing technology has revolutionized the field. CRISPR-based techniques are more accessible, cost-effective, and precise, opening up new possibilities for genome editing applications. Companies invest in research to further refine CRISPR-based tools and expand their applications.

Opportunities

• Environmental Conservation by Enabling the Modification of Organisms

Genome editing can play a role in environmental conservation by enabling the modification of organisms to address ecological challenges, such as invasive species or habitat restoration. Environmental organizations and researchers explore genome editing for conservation efforts to capitalize on this opportunity.

• Gene Therapy Advancements

The development of gene therapy using genome editing techniques presents a significant opportunity. Gene therapies can potentially cure genetic diseases by precisely modifying faulty genes. Biotech firms and research institutions invest in clinical trials and therapeutic development to seize this opportunity.

Restraint/Challenge

• Ethical and Regulatory Challenges

One of the primary restraints in the global genome editing market is the ethical and regulatory complexity of editing the human germline. The potential for unintended consequences and the need for strict ethical guidelines create barriers to certain applications.

This global genome editing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global genome editing market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In November 2021, Precision BioSciences, Inc. and Eli Lilly partnered to create potential in-vivo therapies for genetic illnesses using the latter company's unique ARCUS genome editing platform

Global Genome Editing Market Scope

The global genome editing market is segmented on the basis of technology, application, product and service, method, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• CRISPR
• TALEN
• ZFN
• ANTISENSE
• Other Technologies

Application

• Cell Line Engineering
• Genetic Engineering
• Diagnostic Applications
• Drug Discovery and Development
• Other Applications

 Product and Service

• Reagents
• Consumables

End User

• Pharmaceutical and Biopharmaceutical Industry
• Biotechnology Industry
• Academic Institutions
• CROs
• Government Research Organizations
• Others

 Method

• Ex-Vivo
• In-Vivo

Global Genome Editing Market Regional Analysis/Insights

The global genome editing market is analyzed, and market size insights and trends are provided by country, technology, application, product and service, method, and end user, as referenced above.

The countries covered in the global genome editing market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina, and rest of South America as part of South America.

North America dominates the global genome editing market due to the increased expenditure for research and development proficiencies, increasing government initiatives, and improved healthcare infrastructure in various countries.

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 owing to the increasing government expenditure on the healthcare sector and rising technological advancements and initiatives by the government.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

全球基因组编辑市场还为您提供了每个国家医疗资本设备支出增长、全球基因组编辑市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对全球基因组编辑市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和全球基因组编辑市场份额分析

全球基因组编辑市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

全球基因组编辑市场的一些主要参与者包括：

• 默克集团（德国）
• 金斯瑞 (中国)
• Sangamo Therapeutics（美国）
• 龙沙（瑞士）
• Editas Medicine（美国）
• CRISPR Therapeutics（瑞士）
• Tecan Trading AG（瑞士）
• Precision Biosciences（美国）
• PerkinElmer Inc.（美国）
• Cellectis SA（法国）
• Genome Medical, Inc.（美国）
• BioMed Central Ltd（英国）
• Aevi Genomic Medicine, Inc.（以色列）
• Congenica Ltd.（英国）
• Deep Genomics（加拿大）
• Editas Medicine（美国）
• Illumina 公司（美国）
• 赛默飞世尔科技公司（美国）
• QIAGEN NV（荷兰）
• 安捷伦科技公司（美国）
• Bio-Rad Laboratories, Inc.（美国）

SKU-55033